introduct
may
predispos
venou
arteri
thromboembol
due
excess
inflamm
hypoxia
immobilis
diffus
intravascular
coagul
report
incid
thrombot
complic
howev
avail
method
evalu
incid
composit
outcom
symptomat
acut
pulmonari
embol
pe
deepvein
thrombosi
ischem
stroke
myocardi
infarct
system
arteri
embol
patient
admit
icu
dutch
univers
hospit
dutch
teach
hospit
result
studi
icu
patient
proven
pneumonia
die
discharg
aliv
still
icu
april
patient
receiv
least
standard
dose
thromboprophylaxi
cumul
incid
composit
outcom
ci
ctpa
andor
ultrasonographi
confirm
vte
ci
arteri
thrombot
event
ci
pe
frequent
thrombot
complic
n
age
adjust
hazard
ratio
ahr
year
ci
coagulopathi
defin
spontan
prolong
prothrombin
time
activ
partial
thromboplastin
time
ahr
ci
independ
predictor
thrombot
complic
conclus
incid
thrombot
complic
icu
patient
infect
remark
high
find
reinforc
recommend
strictli
appli
pharmacolog
thrombosi
prophylaxi
patient
admit
icu
strongli
suggest
increas
prophylaxi
toward
highprophylact
dose
even
absenc
random
evid
may
predispos
venou
arteri
thromboembol
diseas
due
excess
inflamm
hypoxia
immobilis
diffus
intravascular
coagul
dic
remark
thrombot
complic
hardli
describ
precis
knowledg
incid
thrombot
complic
patient
import
decis
make
regard
intens
thromboprophylaxi
especi
patient
admit
intens
care
unit
icu
highest
thrombot
risk
evalu
incid
composit
outcom
venou
thromboembol
vte
arteri
thrombot
complic
patient
admit
icu
dutch
univers
hospit
dutch
teach
hospit
composit
outcom
consist
acut
pulmonari
embol
pe
deepvein
thrombosi
dvt
ischem
stroke
myocardi
infarct
system
arteri
embol
importantli
particip
hospit
diagnost
test
appli
thrombot
complic
clinic
suspect
calcul
cumul
incid
composit
outcom
well
venou
arteri
thrombot
complic
separ
index
date
moment
icu
admiss
patient
follow
icu
discharg
die
april
whichev
came
first
perform
backward
condit
regress
analys
identifi
relev
determin
institut
review
board
particip
hospit
waiv
need
inform
consent
due
observ
natur
studi
studi
patient
proven
pneumonia
tabl
admit
icu
march
april
http
die
discharg
aliv
still
icu
april
median
durat
observ
per
patient
day
iqr
patient
receiv
least
standard
dose
thromboprophylaxi
although
regimen
differ
hospit
dose
increas
time
tabl
cumul
incid
composit
outcom
ci
fig
tabl
ctpa
andor
ultrasonographi
confirm
vte
ci
arteri
thrombot
event
ci
pe
frequent
thrombot
complic
n
age
adjust
hazard
ratio
ahr
year
ci
coagulopathi
defin
spontan
prolong
prothrombin
time
activ
partial
thromboplastin
time
ahr
ci
independ
predictor
thrombot
complic
despit
systemat
thrombosi
prophylaxi
incid
thrombot
complic
icu
patient
infect
remark
high
well
compar
vte
incid
patient
categori
overt
dic
notabl
none
patient
actual
develop
dic
consequ
observ
first
repres
conserv
estim
major
patient
still
icu
therefor
risk
describ
observ
period
also
vte
difficult
recogn
intub
patient
higher
threshold
perform
diagnost
imag
test
strict
isol
vte
screen
appli
incid
could
even
higher
acknowledg
due
design
studi
could
adjust
find
actual
administ
dose
nadroparin
studi
effect
chang
local
protocol
thromboprophylaxi
indic
tabl
view
find
reinforc
recommend
strictli
appli
pharmacolog
thrombosi
prophylaxi
patient
admit
icu
suggest
increas
prophylaxi
toward
highprophylact
dose
eg
go
enoxaparin
mg
od
mg
bid
even
absenc
random
evid
final
propos
rather
treat
patient
infect
icu
therapeut
anticoagul
physician
vigil
sign
thrombot
complic
order
appropri
diagnost
test
low
threshold
fak
mjhak
mwh
design
studi
base
observ
dampjg
fak
mjhak
fhjk
mam
njmvdm
kmk
gather
data
fak
mvh
perform
analys
draft
first
version
manuscript
author
revis
manuscript
critic
import
intellectu
content
agre
final
version
